Note 2 - Summary of Significant Accounting Policies (Details Textual) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Feb. 12, 2025 |
Dec. 31, 2024 |
|
| Cash | $ 0 | ||
| Archimedes Tech SPAC Partners II Co | |||
| Cash | 1,362,766 | $ 0 | |
| Cash Equivalents, at Carrying Value | 0 | 0 | |
| Asset, Held-in-Trust, Noncurrent | 239,860,969 | $ 0 | |
| Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | 117,194 | ||
| Payments of Stock Issuance Costs | 283,747 | ||
| Accounts Payable and Accrued Liabilities, Noncurrent | $ 8,050,000 | ||
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 11,920,000 | ||
| Public Warrants [Member] | Archimedes Tech SPAC Partners II Co | |||
| Warrants and Rights Outstanding | $ 1,725,000 | ||
| Warrants and Rights Outstanding, Fair Value Per Share | $ 0.15 | ||
| Initial Public Offering and Private Placement [Member] | Archimedes Tech SPAC Partners II Co | |||
| Payments of Stock Issuance Costs | 4,600,000 | ||
| Accounts Payable and Accrued Liabilities, Noncurrent | 8,050,000 | ||
| Other Expenses | $ 525,520 |
| X | ||||||||||
- Definition Per share fair value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. No definition available.
|
| X | ||||||||||
- Definition Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer), including liabilities for compensation costs, fringe benefits other than pension and postretirement obligations, rent, contractual rights and obligations, and statutory obligations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|